Exploring A Potential 105% Upside In Biotechnology
XOMA Royalty Corporation (XOMA), a name synonymous with innovation in the biotechnology sector, presents an intriguing opportunity for investors. As a royalty aggregator, XOMA focuses on acquiring economic rights to milestone and royalty payments from a diversified portfolio of therapeutic candidates, making it a unique player in the healthcare industry.
**A Closer Look at XOMA’s Market Position**
With a market capitalization of $409.41 million, XOMA operates predominantly in the United States and the Asia Pacific. The company’s strategy involves partnering with other firms to license early to mid-stage clinical assets, primarily those in Phases 1 and 2, and acquiring revenue streams from late-stage or commercial assets. This…
